Company / Assets per Share
Arcutis Biotherapeutics, Inc. Assets per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$3.67
FY2025
5-year range
$3.60 / $8.26
FY2021-FY2025
Trend
+1.9%
vs FY2024
Sector context
#168 of 210
Health Care
What the data says
Arcutis Biotherapeutics, Inc.'s assets per share of $3.67 is lower than 80% of companies in the Health Care sector (FY2025). Assets per Share returned to growth in FY2025 after 5 years of decline, reaching $3.67.
Based on SEC 10-K filings.
3.67 in FY2025 with a 5-year CAGR of -15.2%.
Declined from $4.93 to $3.67 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -23.4%
- 5-Year CAGR
- -15.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 210This company $3.67 Sector average $296.79
▼
-98.8% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 1.9% year-over-year.
- Ranks #168 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2019.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.65 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.67 | +1.9% |
| FY2024 | $3.60 | -26.8% |
| FY2023 | $4.93 | -39.7% |
| FY2022 | $8.16 | -1.2% |
| FY2021 | $8.26 | -1.2% |
| FY2020 | $8.36 | -85.6% |
| FY2019 | $58.06 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026